UK markets closed

Zynex, Inc. (ZYXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.43-0.30 (-2.80%)
As of 03:37PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close10.73
Open10.77
Bid10.38 x 200
Ask10.47 x 100
Day's range10.42 - 10.81
52-week range6.88 - 13.77
Volume98,924
Avg. volume180,222
Market cap331.415M
Beta (5Y monthly)0.49
PE ratio (TTM)45.35
EPS (TTM)0.23
Earnings date25 Jul 2024 - 29 Jul 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date05 Jan 2022
1y target est19.88
  • Zacks

    Are Investors Undervaluing Zynex (ZYXI) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • PR Newswire

    Zynex to Present at the RBC Capital Markets Global Healthcare Conference

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held May 14-15, 2024.

  • Zacks

    3 Reasons Growth Investors Will Love Zynex (ZYXI)

    Zynex (ZYXI) is well positioned to outperform the market, as it exhibits above-average growth in financials.